Elizabeth Bray
Internal Medicine · Murfreesboro, TNNPI 1124061676
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Novo Nordisk at 28.7% of the total. Reporting peaked in 2021 at $842 and has fallen 94.1% since, to $50 in 2022.
Across 136 payments — averaging $13.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$535
- AbbVie$247
- AstraZeneca$217
- Amgen$144
- Astellas Pharma US Inc$143
- Boehringer Ingelheim$59
- plus $521 from 20 others
What the payments were for
- Food & beverage$1,867100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 50 | $535 |
| AbbVie(2 entities) | 18 | $247 |
| AstraZeneca | 13 | $217 |
| Amgen | 10 | $144 |
| Astellas Pharma US Inc | 6 | $143 |
| Boehringer Ingelheim | 4 | $59 |
| Johnson & Johnson | 3 | $55 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| Amarin Pharma, Inc. | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Eisai Inc. | 3 | $40 |
| Pfizer | 3 | $38 |
| Corcept Therapeutics | 2 | $31 |
| Merck | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Novartis | 2 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| GSK | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$1,867 in reported general payments places this provider in the 75th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Murfreesboro
- John AndersonNashville$1.5M
- Tracie WalkerJackson$488K
- Nathan TrenthamEtowah$404K
- Dennis DeruelleKnoxville$263K
- Devin ShermanFranklin$191K
- Lewis HagoodKnoxville$143K
- Temidayo AbeNashville$113K
- Kenya KozawaSweetwater$86K
- Wayne RileyNashville$86K
- Maighan SeagroveChattanooga$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.